Resolution of Pseudophakic Cystoid Macular Edema: 2 mg Intravitreal Triamcinolone Acetonide versus 40 mg Posterior Sub-Tenon Triamcinolone Acetonide.
Publication/Presentation Date
6-1-2021
Abstract
PURPOSE: To compare 2 mg intravitreal triamcinolone (IVT) versus 40 mg posterior sub-Tenon triamcinolone acetonide (STT) for the treatment of eyes with pseudophakic cystoid macular edema.
METHODS: A retrospective, single-center review of eyes receiving 2 mg IVT between 3/1/2012-3/1/2017 and 40 mg STT between 1/1/2015-3/1/2017. Visual acuity (VA) and central macular thickness (CMT) were recorded at baseline, 1-, 3-, and 6-month follow-up visits.
RESULTS: Forty-five eyes were included in the IVT group and 50 eyes in the STT group. Change in VA from baseline to 1, 3, and 6 months was not significantly different between IVT and STT (6 months: 2.3 lines vs. 2.4 lines,
CONCLUSIONS: 2 mg IVT and 40 mg STT both achieved significant improvement in vision and CMT with no significant difference between interventions at 3- and 6-month follow-up.
Volume
46
Issue
6
First Page
824
Last Page
830
ISSN
1460-2202
Published In/Presented At
Kuley, B., Storey, P. P., Wibbelsman, T. D., Pancholy, M., Zhang, Q. E., Sharpe, J., Bello, N., Obeid, A., Regillo, C., Kaiser, R. S., Chiang, A., Fineman, M. S., Vander, J. F., Gupta, O. P., Spirn, M. J., Dunn, J. P., Mehta, S., Park, C. H., Maguire, J. I., & Garg, S. (2021). Resolution of Pseudophakic Cystoid Macular Edema: 2 mg Intravitreal Triamcinolone Acetonide versus 40 mg Posterior Sub-Tenon Triamcinolone Acetonide. Current eye research, 46(6), 824–830. https://doi.org/10.1080/02713683.2020.1842458
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
33522311
Department(s)
Administration and Leadership
Document Type
Article